News & Perspective

Dec 10, 2001

Dec 10, 2001

HHS announces new bioterrorism research initiatives

(CIDRAP News) – The US Department of Health and Human Services (HHS) has announced seven new research grant programs to speed efforts to prevent, diagnose, and treat diseases related to bioterrorism.

Mar 18, 2002

Mar 18, 2002

NIAID releases lengthy bioterrorism research agenda

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.

Apr 16, 2003

Apr 16, 2003

Genetic blueprint of Q fever pathogen decoded

(CIDRAP News) – The genetic blueprint of Coxiella burnetii, a category B bioterrorism agent that causes Q fever, has been decoded and analyzed, the National Institute of Allergy and Infectious Diseases (NIAID) announced this week.

Sep 05, 2003

Sep 05, 2003

HHS funds regional biodefense research centers

(CIDRAP News) – The US Department of Health and Human Services yesterday announced $350 million in grants for eight regional centers to lead and coordinate research on defenses against bioterrorism and emerging infectious diseases.

Sep 30, 2003

Sep 30, 2003

NIAID report claims great progress in biodefense research

(CIDRAP News) – Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.

Oct 01, 2003

Oct 01, 2003

NIAID funds 11 new biodefense labs

(CIDRAP News) – Federal health officials yesterday announced grants to build 11 new biodefense laboratories around the country, including two that will be authorized to study the most dangerous pathogens.

Dec 09, 2003

Dec 09, 2003

NIAID funds tularemia research at New York school

(CIDRAP News) – Albany Medical College in Albany, N.Y., has received an $8.3 million federal grant to study pulmonary tularemia, with the main emphasis on developing a vaccine, college officials announced last week.

The grant from the National Institute of Allergy and Infectious Diseases (NIAID) will fund tularemia research at the college for 4½ years, the college said in a news release.

Mar 12, 2004

Mar 12, 2004

FDA offers guidance on testing drugs for smallpox-shot side effects

(CIDRAP News) – The Food and Drug Administration (FDA) this week published guidelines for the development of drugs to treat the side effects of smallpox vaccination, an area in which the federal government is investing substantial research funds.

Nov 02, 2004

Nov 02, 2004

NIH funds research on how pathogens trigger immune response

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded contracts worth more than $73 million to study the mechanisms by which certain infectious agents, including potential bioterror agents, trigger immune reactions, the National Institutes of Health (NIH) announced yesterday.

Nov 04, 2004

Nov 04, 2004

HHS to spend $877 million on new anthrax vaccine

Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.

(CIDRAP News) – Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»